Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Chemical chaperone and inhibitor discovery: potential treatments for protein conformational diseases.

Zhao JH, Liu HL, Lin HY, Huang CH, Fang HW, Chen SS, Ho Y, Tsai WB, Chen WY.

Perspect Medicin Chem. 2007 Dec 11;1:39-48.

2.

Protein-misfolding diseases and chaperone-based therapeutic approaches.

Chaudhuri TK, Paul S.

FEBS J. 2006 Apr;273(7):1331-49. Review.

3.

Protein conformational diseases: from mechanisms to drug designs.

Lin JC, Liu HL.

Curr Drug Discov Technol. 2006 Jun;3(2):145-53. Review.

PMID:
16925522
4.

Mechanisms of disease II: cellular protein quality control.

Outeiro TF, Tetzlaff J.

Semin Pediatr Neurol. 2007 Mar;14(1):15-25. Review.

PMID:
17331880
5.

Molecular chaperones biochemistry and role in neurodegenerative diseases.

Chaari A.

Int J Biol Macromol. 2019 Jun 15;131:396-411. doi: 10.1016/j.ijbiomac.2019.02.148. Epub 2019 Mar 7. Review.

PMID:
30853582
6.

Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.

Meredith SC.

Ann N Y Acad Sci. 2005 Dec;1066:181-221. Review.

PMID:
16533927
7.

Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation.

Zaman M, Khan AN, Wahiduzzaman, Zakariya SM, Khan RH.

Int J Biol Macromol. 2019 Aug 1;134:1022-1037. doi: 10.1016/j.ijbiomac.2019.05.109. Epub 2019 May 22. Review.

PMID:
31128177
8.

[Neurodegenerative conformational disease and its molecular bases].

Li WW, Cai DF, Ren HM.

Sheng Li Ke Xue Jin Zhan. 2006 Apr;37(2):97-102. Review. Chinese.

PMID:
16850610
9.
10.

Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.

Naeem A, Fazili NA.

Cell Biochem Biophys. 2011 Nov;61(2):237-50. doi: 10.1007/s12013-011-9200-x. Review.

PMID:
21573992
11.

Chemical chaperones: mechanisms of action and potential use.

Papp E, Csermely P.

Handb Exp Pharmacol. 2006;(172):405-16.

PMID:
16610368
12.

Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases.

Nagai Y, Fujikake N, Popiel HA, Wada K.

Curr Pharm Biotechnol. 2010 Feb;11(2):188-97. Review.

PMID:
20166962
13.

Modulation of neurodegeneration by molecular chaperones.

Muchowski PJ, Wacker JL.

Nat Rev Neurosci. 2005 Jan;6(1):11-22. Review.

PMID:
15611723
14.

Biological and chemical approaches to diseases of proteostasis deficiency.

Powers ET, Morimoto RI, Dillin A, Kelly JW, Balch WE.

Annu Rev Biochem. 2009;78:959-91. doi: 10.1146/annurev.biochem.052308.114844. Review.

PMID:
19298183
15.

Opportunities and challenges for molecular chaperone modulation to treat protein-conformational brain diseases.

van der Putten H, Lotz GP.

Neurotherapeutics. 2013 Jul;10(3):416-28. doi: 10.1007/s13311-013-0186-5. Review.

16.

Protein aggregation.

Merlini G, Bellotti V, Andreola A, Palladini G, Obici L, Casarini S, Perfetti V.

Clin Chem Lab Med. 2001 Nov;39(11):1065-75.

PMID:
11831622
17.

Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration.

Burke KA, Yates EA, Legleiter J.

Front Neurol. 2013 Mar 1;4:17. doi: 10.3389/fneur.2013.00017. eCollection 2013.

18.

[Pharmacological chaperones: a potential therapeutic treatment for conformational diseases].

Mendre C, Mouillac B.

Med Sci (Paris). 2010 Jun-Jul;26(6-7):627-35. doi: 10.1051/medsci/2010266-7627. Review. French.

19.

Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures.

Sablón-Carrazana M, Fernández I, Bencomo A, Lara-Martínez R, Rivera-Marrero S, Domínguez G, Pérez-Perera R, Jiménez-García LF, Altamirano-Bustamante NF, Diaz-Delgado M, Vedrenne F, Rivillas-Acevedo L, Pasten-Hidalgo K, Segura-Valdez Mde L, Islas-Andrade S, Garrido-Magaña E, Perera-Pintado A, Prats-Capote A, Rodríguez-Tanty C, Altamirano-Bustamante MM.

PLoS One. 2015 Sep 1;10(9):e0135292. doi: 10.1371/journal.pone.0135292. eCollection 2015.

20.

Unraveling the mysteries of protein folding and misfolding.

Ecroyd H, Carver JA.

IUBMB Life. 2008 Dec;60(12):769-74. doi: 10.1002/iub.117. Review.

Supplemental Content

Support Center